Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TCF25 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | PARP1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
mRNA | LSM6 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
mRNA | MRPL55 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | C19orf24 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | EBPL | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | CETP | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | DLL3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
mRNA | GSTA4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
mRNA | ZBTB37 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |